This inventor holds 5 USPTO granted patents and 2 EPO patents. Top assignees: Lg Electronics Inc., Therasid Bioscience Inc., Seoul National University. Active years: 2013-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Seoul, KR (2020)
- Gyeonggi-Do, KR (2013 - 2022)
Company Filing History:


Years Active: 2013-2022
Title: Wooyoung Kwak: Innovator in Pharmaceutical Compounds
Introduction
Wooyoung Kwak is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceutical compounds, holding a total of 5 patents. His work primarily focuses on the development of novel compounds that can be utilized in the treatment of various diseases.
Latest Patents
Kwak's latest patents include innovative formulations of 1-(4-benzyloxy-benzyl)-3-methyl-thiourea. One of his patents describes the compound in crystalline forms A, B, C, or amorphous form. This patent outlines a method for preparing the compound in these forms and its potential use in preventing or treating metabolic and inflammatory diseases. Another patent details a method for preparing novel crystalline forms of the same compound, emphasizing the creation of a stable crystalline form A.
Career Highlights
Throughout his career, Wooyoung Kwak has worked with prominent companies such as LG Electronics Inc. and Therasid Bioscience Inc. His experience in these organizations has allowed him to refine his skills in research and development, particularly in the pharmaceutical sector.
Collaborations
Kwak has collaborated with several professionals in his field, including coworkers Sungki Seo and Heung Jae Kim. These collaborations have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Wooyoung Kwak is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact the treatment of various diseases. His innovative approaches and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile